Genetics in primary sclerosing cholangitis

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 6, 2011, Pages 713-726

  Folseraas, Trine ^a   Melum, Espen ^a   Franke, Andre ^a   Karlsen, Tom H ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Genetic susceptibility; Genome wide association study; Primary sclerosing cholangitis

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B4; ADAPTOR PROTEIN; CONSTITUTIVE ANDROSTANE RECEPTOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; ETANERCEPT; HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DR ANTIGEN; PREGNANE X RECEPTOR; PROTEIN CARD9; RIFAMPICIN; TACROLIMUS; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; BILE DUCT CARCINOMA; CROHN DISEASE; DNA MODIFICATION; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL MODEL; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HEPATITIS; HEREDITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; RHEUMATOID ARTHRITIS; SIBLING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ANIMALS; CHOLANGITIS, SCLEROSING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE;

EID: 82255165459     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.09.010     Document Type: Article

References (90)

1. A. Bergquist, S.M. Montgomery, and S. Bahmanyar Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis Clin Gastroenterol Hepatol 6 2008 939 943
2. T.H. Karlsen, E. Schrumpf, and K.M. Boberg Update on primary sclerosing cholangitis Dig Liver Dis 42 2010 390 400
3. S. Saarinen, O. Olerup, and U. Broome Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis Am J Gastroenterol 95 2000 3195 3199
4. A. Bergquist, A. Ekbom, and R. Olsson Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 2002 321 327 (Pubitemid 34194790)
5. A. Zhernakova, C.C. van Diemen, and C. Wijmenga Detecting shared pathogenesis from the shared genetics of immune-related diseases Nat Rev Genet 10 2009 43 55
6. T.H. Karlsen, E. Melum, and A. Franke The utility of genome-wide association studies in hepatology Hepatology 2010
7. M. Ghoussaini, H. Song, and T. Koessler Multiple loci with different cancer specificities within the 8q24 gene desert J Natl Cancer Inst 100 2008 962 966 (Pubitemid 351957516)
8. S.A. Tishkoff, and B.C. Verrelli Role of evolutionary history on haplotype block structure in the human genome: implications for disease mapping Curr Opin Genet Dev 13 2003 569 575 (Pubitemid 37456873)
9. J.A. Traherne Human MHC architecture and evolution: implications for disease association studies Int J Immunogenet 35 2008 179 192 (Pubitemid 351678693)
10. J. Kelley, and J. Trowsdale Features of MHC and NK gene clusters Transpl Immunol 14 2005 129 134 (Pubitemid 40848517)
11. R. Horton, L. Wilming, and V. Rand Gene map of the extended human MHC Nat Rev Genet 5 2004 889 899 (Pubitemid 39564252)
12. R.W. Chapman, Z. Varghese, and R. Gaul Association of primary sclerosing cholangitis with HLA-B8 Gut 24 1983 38 41 (Pubitemid 13170184)
13. E. Schrumpf, O. Fausa, and O. Forre HLA antigens and immunoregulatory T-cells in ulcerative colitis associated with hepatobiliary disease Scand J Gastroenterol 17 1982 187 191 (Pubitemid 12185520)
14. P.T. Donaldson, J.M. Farrant, and M.L. Wilkinson Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis Hepatology 13 1991 129 133
15. A. Spurkland, S. Saarinen, and K.M. Boberg HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations Tissue Antigens 53 1999 459 469 (Pubitemid 29224484)
16. J.P. McElroy, B.A. Cree, and S.J. Caillier Refining the association of MHC with multiple sclerosis in African Americans Hum Mol Genet 19 2010 3080 3088
17. C.L. Bowlus, C.S. Li, and T.H. Karlsen Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations Liver Transpl 16 2010 1324 1330
18. E. Melum, A. Franke, and C. Schramm Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci Nat Genet 43 2011 17 19
19. S. Norris, E. Kondeatis, and R. Collins Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism Gastroenterology 120 2001 1475 1482 (Pubitemid 32322322)
20. K. Wiencke, A. Spurkland, and E. Schrumpf Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles Hepatology 34 2001 625 630 (Pubitemid 32927984)
21. S. Gaudieri, J.K. Kulski, and R.L. Dawkins Different evolutionary histories in two subgenomic regions of the major histocompatibility complex Genome Res 9 1999 541 549 (Pubitemid 29361270)
22. T.H. Karlsen, K.M. Boberg, and M. Olsson Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis J Hepatol 46 2007 899 906 (Pubitemid 46529047)
23. J.R. Hov, A. Lleo, and C. Selmi Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C J Hepatol 52 2010 712 717
24. A.A. Zachary, W.B. Bias, and A. Johnson Antigen, allele, and haplotype frequencies report of the ASHI minority antigens workshops: part 1, African-Americans Hum Immunol 62 2001 1127 1136 (Pubitemid 32971390)
25. L.M. Sollid, and E. Thorsby The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations Tissue Antigens 36 1990 136 137 (Pubitemid 20376625)
26. J.R. Hov, V. Kosmoliaptsis, and J.A. Traherne Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis Hepatology 53 2011 1967 1976
27. T.H. Karlsen, and A. Kaser Deciphering the genetic predisposition to primary sclerosing cholangitis Semin Liver Dis 31 2011 188 207
28. C.A. Dendrou, V. Plagnol, and E. Fung Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource Nat Genet 41 2009 1011 1015
29. T.R. Malek, and I. Castro Interleukin-2 receptor signaling: at the interface between tolerance and immunity Immunity 33 2010 153 165
30. P. Bouillet, D. Metcalf, and D.C. Huang Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity Science 286 1999 1735 1738 (Pubitemid 129515880)
31. D.A. Hildeman, Y. Zhu, and T.C. Mitchell Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim Immunity 16 2002 759 767 (Pubitemid 34786475)
32. S. Vallabhapurapu, and M. Karin Regulation and function of NF-kappaB transcription factors in the immune system Annu Rev Immunol 27 2009 693 733
33. H.C. Liou, and C.Y. Hsia Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease Bioessays 25 2003 767 780 (Pubitemid 36966377)
34. H. Hara, and T. Saito CARD9 versus CARMA1 in innate and adaptive immunity Trends Immunol 30 2009 234 242
35. Y.Q. Zhou, Y.Q. Chen, and J.H. Fisher Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages J Biol Chem 277 2002 38104 38110 (Pubitemid 35154662)
36. P. Goyette, C. Lefebvre, and A. Ng Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis Mucosal Immunol 1 2008 131 138
37. U. Beuers, S. Hohenester, and L.J. de Buy Wenniger The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies Hepatology 52 2010 1489 1496
38. T.H. Karlsen, A. Franke, and E. Melum Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 2010 1102 1111
39. C. Colombo Liver disease in cystic fibrosis Curr Opin Pulm Med 13 2007 529 536 (Pubitemid 47494203)
40. S. Sheth, J.C. Shea, and M.D. Bishop Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis Hum Genet 113 2003 286 292 (Pubitemid 36992289)
41. H. Pall, J. Zielenski, and M.M. Jonas Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function J Pediatr 151 2007 255 259 (Pubitemid 47284133)
42. K. Okamoto, K. Tokunaga, and K. Doi Common variation in GPC5 is associated with acquired nephrotic syndrome Nat Genet 43 2011 459 463
43. T.H. Karlsen, B.A. Lie, and K. Frey Froslie Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis Gastroenterology 131 2006 781 787 (Pubitemid 44307062)
44. E. Melum, K.M. Boberg, and A. Franke Variation in the MDR3 gene influences disease progression in PSC patients and disease susceptibility in epistatic interaction with polymorphism in OST-alpha gene Hepatology 46 2007 265A
45. Y. Ohishi, M. Nakamura, and N. Iio Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis Hepatology 48 2008 853 862
46. S. Sookoian, G.O. Castano, and A.L. Burgueno The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease Pharmacogenet Genomics 20 2010 1 8
47. M. Wagner, E. Halilbasic, and H.U. Marschall CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice Hepatology 42 2005 420 430 (Pubitemid 41061095)
48. E.L. Haughton, S.J. Tucker, and C.J. Marek Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro Gastroenterology 131 2006 194 209 (Pubitemid 44015746)
49. C. Zhou, M.M. Tabb, and E.L. Nelson Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation J Clin Invest 116 2006 2280 2289 (Pubitemid 44162338)
50. T.H. Mauad, C.M. van Nieuwkerk, and K.P. Dingemans Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis Am J Pathol 145 1994 1237 1245
51. D. Gotthardt, H. Runz, and V. Keitel A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults Hepatology 48 2008 1157 1166
52. K.M. Boberg, A. Bergquist, and S. Mitchell Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand J Gastroenterol 37 2002 1205 1211 (Pubitemid 35189610)
53. T. Hayashi, K. Imai, and Y. Morishita Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance Cancer Res 66 2006 563 570 (Pubitemid 43166065)
54. E. Melum, T.H. Karlsen, and E. Schrumpf Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms Hepatology 47 2008 90 96 (Pubitemid 351171045)
55. V. Kumar, N. Kato, and Y. Urabe Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma Nat Genet 43 2011 455 458
56. J.M. Vierling Animal models for primary sclerosing cholangitis Best Pract Res Clin Gastroenterol 15 2001 591 610 (Pubitemid 32747013)
57. M.J. Pollheimer, M. Trauner, and P. Fickert Will we ever model PSC? - "It's hard to be a PSC model!" Clin Res Hepatol Gastroeneterol 2011
58. P.H. Correll, A. Iwama, and S. Tondat Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase Genes Funct 1 1997 69 83
59. M. Trauner, P. Fickert, and A. Baghdasaryan New insights into autoimmune cholangitis through animal models Dig Dis 28 2010 99 104
60. P.G. Blanco, M.M. Zaman, and O. Junaidi Induction of colitis in cftr-/- mice results in bile duct injury Am J Physiol Gastrointest Liver Physiol 287 2004 G491 G496 (Pubitemid 38955270)
61. R. Fiorotto, R. Scirpo, and M. Trauner Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice Gastroenterology 141 2011 1498 1508 e1495
62. T. Kireva, A. Erhardt, and G. Tiegs Transcription factor Fra-1 induces cholangitis and liver fibrosis Hepatology 53 2011 1259 1269
63. Y.H. Chuang, W.M. Ridgway, and Y. Ueno Animal models of primary biliary cirrhosis Clin Liver Dis 12 2008 333 347 ix (Pubitemid 351626674)
64. G.M. Hirschfield, and P. Invernizzi Progress in the genetics of primary biliary cirrhosis Semin Liver Dis 31 2011 147 156
65. J. Irie, Y. Wu, and L.S. Wicker NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis J Exp Med 203 2006 1209 1219 (Pubitemid 43736591)
66. J.C. Barrett, S. Hansoul, and D.L. Nicolae Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat Genet 40 2008 955 962
67. A. Franke, D.P. McGovern, and J.C. Barrett Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nat Genetics 42 2010 1118 1125
68. J. Stallhofer, G.U. Denk, and J. Glas Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis Digestion 84 2011 29 35
69. M. Janse, L.E. Lamberts, and L. Franke Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9 Hepatology 53 2011 1977 1985
70. K. Kyokane, T. Ichihara, and M. Horisawa Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid Hepatogastroenterology 41 1994 449 452 (Pubitemid 24340643)
71. R. Wiesner, B. Steiner, and N. LaRusso A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis Hepatology 14 1991 A64 [Abstract]
72. W.J. Sandborn, R.H. Wiesner, and W.J. Tremaine Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin Gut 34 1993 242 246 (Pubitemid 23049120)
73. J.A. Talwalkar, A.A. Gossard, and J.C. Keach Tacrolimus for the treatment of primary sclerosing cholangitis Liver Int 27 2007 451 453 (Pubitemid 46534566)
74. K.M. Boberg, T. Egeland, and E. Schrumpf Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients Scand J Gastroenterol 38 2003 991 995 (Pubitemid 37158028)
75. V. Giljaca, G. Poropat, and D. Stimac Glucocorticosteroids for primary sclerosing cholangitis Cochrane Database Syst Rev 2010 CD004036
76. D.A. Hafler, A. Compston, and S. Sawcer Risk alleles for multiple sclerosis identified by a genomewide study N Engl J Med 357 2007 851 862 (Pubitemid 47347319)
77. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678
78. P.T. Donaldson, and S. Norris Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis Autoimmunity 35 2002 555 564 (Pubitemid 36321898)
79. K. Wiencke, T.H. Karlsen, and K.M. Boberg Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes Tissue Antigens 69 2007 161 169 (Pubitemid 46174871)
80. A. Strasser The role of BH3-only proteins in the immune system Nat Rev Immunol 5 2005 189 200 (Pubitemid 40364821)
81. T. Maruyama, K. Tanaka, and J. Suzuki Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice J Endocrinol 191 2006 197 205 (Pubitemid 44756522)
82. G. Vassileva, A. Golovko, and L. Markowitz Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation Biochem J 398 2006 423 430 (Pubitemid 44453386)
83. R.G. Gieling, A.M. Elsharkawy, and J.H. Caamano The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation Hepatology 51 2010 922 931
84. F. Kontgen, R.J. Grumont, and A. Strasser Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression Genes Dev 9 1995 1965 1977
85. J.A. Bezerra, T.L. Carrick, and J.L. Degen Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice J Clin Invest 101 1998 1175 1183 (Pubitemid 28125297)
86. H. Schorle, T. Holtschke, and T. Hunig Development and function of T-cells in mice rendered interleukin-2 deficient by gene targeting Nature 352 1991 621 624 (Pubitemid 21912393)
87. B. Sadlack, H. Merz, and H. Schorle Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 1993 253 261 (Pubitemid 23320289)
88. H. Hara, C. Ishihara, and A. Takeuchi The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors Nat Immunol 8 2007 619 629 (Pubitemid 46785126)
89. Y.M. Hsu, Y. Zhang, and Y. You The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens Nat Immunol 8 2007 198 205 (Pubitemid 46152651)
90. W. Hsu, W. Zhang, and K. Tsuneyama Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice Hepatology 49 2009 133 140